Valuation: Isodiol International Inc.

Market Cap 3.91M 2.75M 2.41M 2.21M 2.06M 262M 3.97M 26.56M 10.32M 129M 10.34M 10.11M 444M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.43M 5.62M 5.17M 4.82M 612M 9.27M 62.02M 24.11M 301M 24.14M 23.62M 1.04B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
Current year 0
Extreme 0
0
1 year 0
Extreme 0
0
3 years 0
Extreme 0
0
5 years 0
Extreme 0
0.29
10 years 0
Extreme 0
16.9
Manager TitleAgeSince
Chief Executive Officer - 2017-05-23
Director of Finance/CFO - -
Corporate Officer/Principal - 2018-08-29
Director TitleAgeSince
Director/Board Member - 2017-05-23
Director/Board Member - 2018-08-29
Director/Board Member - 2018-11-20
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 128
+0.21%+3.96%-12.42%-7.50% 12.84B
+0.34%+4.33%-34.60%-57.67% 4.72B
-0.02%+8.30%-7.96%-5.57% 4.46B
+2.23%+12.59%+23.21%-5.62% 3.91B
+1.10%+6.55%+4.13%-39.48% 3.84B
+1.74%+5.74%-12.12%-0.99% 3.08B
+0.13%-11.54%-13.71%-20.54% 3.05B
+0.79%+6.47%-7.94%-25.15% 2.38B
+0.53%+7.02%-11.86%+33.48% 1.72B
Average +0.70%+0.07%-8.14%-14.34% 4B
Weighted average by Cap. +0.64%+0.26%-9.25%-15.87%

Financials

2018 2019
Net sales 19.14M 13.47M 11.78M 10.82M 10.09M 1.28B 19.43M 130M 50.52M 631M 50.57M 49.49M 2.17B 22.25M 15.66M 13.69M 12.58M 11.73M 1.49B 22.59M 151M 58.73M 733M 58.8M 57.53M 2.53B
Net income -36.02M -25.36M -22.17M -20.37M -18.99M -2.41B -36.57M -245M -95.09M -1.19B -95.19M -93.15M -4.09B -126M -88.65M -77.5M -71.22M -66.38M -8.44B -128M -855M -332M -4.15B -333M -326M -14.3B
Net Debt -15.55M -10.95M -9.57M -8.8M -8.2M -1.04B -15.79M -106M -41.05M -512M -41.09M -40.21M -1.77B 5.22M 3.68M 3.21M 2.95M 2.75M 350M 5.3M 35.46M 13.79M 172M 13.8M 13.5M 593M
Logo Isodiol International Inc.
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. ISOLF Stock